In medical weight loss, semaglutide may help appropriate patients by supporting fullness after smaller meals, reducing appetite and food noise, improving portion control, supporting blood sugar regulation, helping some patients improve cardiometabolic risk markers, and supporting weight loss when combined with nutrition, activity, and medical monitoring
In published research it has been investigated for its effects on tissue repair, angiogenesis, gastrointestinal mucosal protection and anti-inflammatory signalling in animal and cell-culture models
Our patients will typically see a 10-15 pound weight loss over the first 3 months.
Some common medication interactions to be careful of include: Utilizing Rybelsus in conjunction with insulin or insulin secretagogues (such as sulfonylureas) may elevate the likelihood of hypoglycemia, or low blood sugar
Semaglutide is a lab-made version of this hormone that is roughly 94% similar to the natural one, but chemically modified so it stays active in the body for almost a full week instead of just minutes